VIA
ABMD

Vident Investment Advisory’s Abiomed Inc ABMD Stock Holding History

Vident Investment Advisory’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,075
Closed -$478K – 1377
2022
Q3 		$478K Buy
2,075
+423
+26% +$114K 0.02% 793
2022
Q2 		$402K Sell
1,652
-526
-24% -$142K 0.01% 921
2022
Q1 		$722K Sell
2,178
-2,432
-53% -$749K 0.02% 811
2021
Q4 		$1.66M Sell
4,610
-379
-8% -$128K 0.04% 534
2021
Q3 		$1.62M Buy
4,989
+202
+4% +$68.4K 0.05% 524
2021
Q2 		$1.49M Sell
4,787
-461
-9% -$141K 0.05% 522
2021
Q1 		$1.67M Sell
5,248
-30
-0.6% -$9.6K 0.06% 453
2020
Q4 		$1.71M Buy
5,278
+141
+3% +$39K 0.07% 345
2020
Q3 		$1.42M Buy
5,137
+1,696
+49% +$489K 0.07% 390
2020
Q2 		$831K Buy
3,441
+1,829
+113% +$367K 0.04% 531
2020
Q1 		$234K Buy
1,612
+93
+6% +$15.4K 0.02% 731
2019
Q4 		$259K Buy
+1,519
New +$282K 0.02% 652
2017
Q1 		– Sell
-3,112
Closed -$351K – 500
2016
Q4 		$351K Sell
3,112
-868
-22% -$101K 0.04% 354
2016
Q3 		$512K Sell
3,980
-2,496
-39% -$299K 0.07% 340
2016
Q2 		$708K Sell
6,476
-18,464
-74% -$1.84M 0.1% 315
2016
Q1 		$2.36K Buy
+24,940
New +$2.11M 0.15% 265

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vident Investment Advisory's ABMD Position: Q4 2022 in Review

Vident Investment Advisory sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,075 shares — an estimated $478K sold.

Vident Investment Advisory first reported a position in ABMD in Q1 2016 and held it in 16 quarters. The position peaked at $1.71M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Vident Investment Advisory reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 2,075 Abiomed Inc shares in Q4 2022, an estimated $478K.
  • Vident Investment Advisory first reported a position in Abiomed Inc in Q1 2016 and held it in 16 quarters.
  • Vident Investment Advisory's Abiomed Inc position peaked at $1.71M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.